Comparison of ipragliflozin and pioglitazone effects on nonalcoholic fatty liver disease in patients with type 2 diabetes: a randomized, 24-week, open-label, active-controlled trial
This means that in the worst-case scenario when you lose weight using a GLP-1 agonist, the weight you lose when you weigh yourself is 50% from a loss of muscle mass and 50% from a loss of fat mass
Losing large amounts of weight can be emotionally taxing, and the weight loss journey can be long
Clinical trials have demonstrated reductions in digital eye fatigue and eye strain symptoms, improvements in visual acuity, and potential protective effects against age-related macular changes
No matter what weve done, weve not been able to nail precisely why they are resistant. Unexpected resistance The researchers focused on two genetic variants that handicap an enzyme known as PAM (peptidyl-glycine alpha-amidating monooxygenase), which is uniquely capable of activating many hormones in the body, including GLP-1
Attenuated Salmonella-based vaccines also have a cheap cost of manufacture